Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAshtead Group Regulatory News (AHT)

  • There is currently no data for AHT

Director/PDMR Shareholding

21 Jun 2024 15:30

Ashtead Group Plc - Director/PDMR Shareholding

Ashtead Group Plc - Director/PDMR Shareholding

PR Newswire

LONDON, United Kingdom, June 21

Ashtead Group plc

 

21 June 2024

 

 

 

ASHTEAD GROUP PLC

 

Director / PDMR Shareholding

 

 

Ashtead Group plc (the "Company") announces that on 20 June 2024 it made awards under its Long-Term Incentive Plan ("LTIP").

 

Awards under the LTIP comprise the conditional right to receive ordinary shares of 10p each. Vesting of awards is subject to continued employment and the achievement of challenging performance targets set by the Remuneration Committee. The Company intends to utilise shares held by the Group's Employee Share Ownership Trust to fulfil any obligations to award shares to employees, which may arise.

 

Executive directors, who were directors at time the awards were made are required to hold any vested shares, after selling sufficient shares to fund their tax liability, for a further two years from the date of vesting.

The following awards were made to the executive directors:

Director

Number of ordinary 10p shares covered by the award

Brendan Horgan

59,390

Michael Pratt

26,333

 

The closing mid-market share price on the award date was 5,434p.

 

The exercise price for the above awards is GBP1 for all ordinary shares to which the award relates. No consideration was paid for the grant of any of these awards.

 

 

 

Contact:

 

Will Shaw

Tel: 020 7726 9761



Date   Source Headline
10th Jun 20215:22 pmPRNTransaction in Own Shares
9th Jun 20215:10 pmPRNTransaction in Own Shares
8th Jun 20216:25 pmPRNTransaction in Own Shares
7th Jun 20215:07 pmPRNTransaction in Own Shares
7th Jun 20219:54 amPRNNotice of Results
4th Jun 20215:18 pmPRNTransaction in Own Shares
3rd Jun 20215:40 pmPRNTransaction in Own Shares
2nd Jun 20215:18 pmPRNTransaction in Own Shares
1st Jun 20215:25 pmPRNTransaction in Own Shares
28th May 20215:14 pmPRNTransaction in Own Shares
27th May 20215:33 pmPRNTransaction in Own Shares
27th May 20214:41 pmRNSSecond Price Monitoring Extn
27th May 20214:36 pmRNSPrice Monitoring Extension
26th May 20215:24 pmPRNTransaction in Own Shares
25th May 20215:23 pmPRNTransaction in Own Shares
24th May 20215:32 pmPRNTransaction in Own Shares
21st May 20216:12 pmPRNTransaction in Own Shares
20th May 20215:19 pmPRNTransaction in Own Shares
19th May 20215:14 pmPRNTransaction in Own Shares
18th May 20215:14 pmPRNTransaction in Own Shares
17th May 20215:17 pmPRNTransaction in Own Shares
14th May 20215:16 pmPRNTransaction in Own Shares
13th May 20215:35 pmPRNTransaction in Own Shares
12th May 20215:31 pmPRNTransaction in Own Shares
11th May 20215:14 pmPRNTransaction in Own Shares
10th May 20215:45 pmPRNTransaction in Own Shares
7th May 20215:27 pmPRNTransaction in Own Shares
6th May 20215:30 pmPRNTransaction in Own Shares
5th May 20215:49 pmPRNTransaction in Own Shares
4th May 20215:55 pmPRNTransaction in Own Shares
4th May 20214:02 pmPRNDirectorate Update
4th May 20217:01 amPRNPurchase of Shares
30th Apr 202111:14 amPRNDirectorate Update
21st Apr 202110:05 amPRNDirectorate Change
20th Apr 202112:00 pmRNSCapital markets event and trading update
1st Apr 202112:52 pmPRNTotal Voting Rights
2nd Mar 20217:00 amRNSResults for the nine months & Q3 ended 31/01/2021
1st Mar 20219:31 amPRNTotal Voting Rights
23rd Feb 202112:12 pmPRNNotice of Results
1st Feb 202110:57 amPRNTotal Voting Rights
25th Jan 202111:26 amPRNDirectorate Update
4th Jan 202111:51 amPRNTotal Voting Rights
14th Dec 20209:47 amPRNHolding(s) in Company
8th Dec 20207:00 amRNSUnaudited results Interim & Q2 ended 31/10/2020
4th Dec 202011:14 amPRNTotal Voting Rights: Correction
4th Dec 20209:05 amPRNDirectorate Update
1st Dec 202012:20 pmPRNTotal Voting Rights
23rd Nov 20203:36 pmPRNNotice of Results
2nd Nov 202010:55 amPRNTotal Voting Rights
8th Oct 20205:09 pmRNSReduction of Capital

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.